NCT06246006View on ClinicalTrials.gov

Functional Characterization of Thrombopoietin/cMPL Receptor Mutations in Myeloproliferative Neoplasia

Active, not recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Myeloproliferative Disorder
Interventions
OTHER

Gene sequencing

Next generation sequencing of candidate genes (JAK2, cMPL, CALR, ASXL1 and NF-E2)

Trial Locations (1)

Unknown

CHU de Nîmes, Nîmes

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT06246006 - Functional Characterization of Thrombopoietin/cMPL Receptor Mutations in Myeloproliferative Neoplasia | Biotech Hunter | Biotech Hunter